These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 8817097)
1. Immunophenotyping of congenital leukemia. Brissette M; Simurdak J; Larsen R; Hodges G Cytometry; 1996 Jun; 26(2):180-1. PubMed ID: 8817097 [No Abstract] [Full Text] [Related]
2. [Immunophenotyping of acute lymphoblastic leukemia in Mexican children]. Paredes-Aguilera R; Romero-Guzmán L; López-Santiago N; Bravo-Lindoro A; Correa-González C; Joly-Linero R; Nieto-Martínez S; del Campo-Martínez A Sangre (Barc); 1999 Jun; 44(3):188-94. PubMed ID: 10481579 [TBL] [Abstract][Full Text] [Related]
3. Precursor B lymphoblastic leukemia with surface light chain immunoglobulin restriction: a report of 15 patients. Kansal R; Deeb G; Barcos M; Wetzler M; Brecher ML; Block AW; Stewart CC Am J Clin Pathol; 2004 Apr; 121(4):512-25. PubMed ID: 15080303 [TBL] [Abstract][Full Text] [Related]
4. CD19 negative precursor B acute lymphoblastic leukemia presenting with hypercalcemia. Sultan I; Kraveka JM; Lazarchick J Pediatr Blood Cancer; 2004 Jul; 43(1):66-9. PubMed ID: 15170892 [TBL] [Abstract][Full Text] [Related]
5. Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the Pediatric Oncology Group. Borowitz MJ; Carroll AJ; Shuster JJ; Look AT; Behm FG; Pullen DJ; Land VJ; Steuber P; Crist WM Recent Results Cancer Res; 1993; 131():257-67. PubMed ID: 8210645 [No Abstract] [Full Text] [Related]
6. Precursor B lymphoblastic leukemia 32 months after local therapy for a primary extramedullary myeloid cell tumor. Szinnai G; Cogliatti SB; Avoledo P; Dirnhofer S; Schmid U; Kühne T Pediatr Blood Cancer; 2007 Dec; 49(7):1039-46. PubMed ID: 16572408 [TBL] [Abstract][Full Text] [Related]
10. Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity. Attarbaschi A; Mann G; König M; Steiner M; Strehl S; Schreiberhuber A; Schneider B; Meyer C; Marschalek R; Borkhardt A; Pickl WF; Lion T; Gadner H; Haas OA; Dworzak MN Clin Cancer Res; 2006 May; 12(10):2988-94. PubMed ID: 16707593 [TBL] [Abstract][Full Text] [Related]
11. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1. Kasai M; Akatsuka Y; Emi N; Taji H; Kohno A; Abe A; Tanimoto M; Kodera Y; Saito H Int J Hematol; 1999 Feb; 69(2):112-8. PubMed ID: 10071461 [TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection. Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection. DiGiuseppe JA; Fuller SG; Borowitz MJ Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072 [TBL] [Abstract][Full Text] [Related]
14. CD5-positive acute lymphoblastic leukemia. Ahmed D; Ahmed TA; Ahmed S; Tipu HN; Wiqar MA J Coll Physicians Surg Pak; 2008 May; 18(5):310-1. PubMed ID: 18541090 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of clinical characteristics and immunophenotype of CD45(-) and CD45(+) B-acute lymphoblastic leukemia]. Zhang ZH; Jiang M; Qu JH Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):792-3. PubMed ID: 22339921 [No Abstract] [Full Text] [Related]
16. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [TBL] [Abstract][Full Text] [Related]